Viewing StudyNCT00482911



Ignite Creation Date: 2024-05-05 @ 5:35 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00482911
Status: TERMINATED
Last Update Posted: 2017-03-27
First Post: 2007-06-04

Brief Title: Lenalidomide Sunitinib and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma
Sponsor: National Institutes of Health Clinical Center CC
Organization: National Institutes of Health Clinical Center CC

Organization Data

Organization: National Institutes of Health Clinical Center CC
Class: NIH
Study ID: 070134
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: National Institutes of Health Clinical Center CC
Lead Sponsor Class: NIH
Responsible Party: Caryn Steakley RN
Responsible Party Title: Deputy Clinical Director Center for Cancer Research
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: National Institutes of Health Clinical Center CC
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH